Gene · 4627
Papers4,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fine mapping of the antigenic epitopes of the Gc protein of Guertu virus. | PLoS One | 2022 | 35881569 | PubTator, text mining | PubMed |
| N-glycoproteomic profiling revealing novel coronavirus therapeutic targets potentially involved in Cepharanthine's intervention. | Med Nov Technol Devices | 2022 | 35879945 | PubTator, text mining | PubMed |
| Pathogenic Variants in Cardiomyopathy Disorder Genes Underlie Pediatric Myocarditis-Further Impact of Heterozygous Immune Disorder Gene Variants? | J Cardiovasc Dev Dis | 2022 | 35877578 | PubTator, text mining | PubMed |
| Application of Multi-Omics Approach in Sarcomas: A Tool for Studying Mechanism, Biomarkers, and Therapeutic Targets. | Front Oncol | 2022 | 35875106 | PubTator, text mining | PubMed |
| Exploring the function of factor XIII free B subunit: Interactions with complement factors and a novel approach to identify potential binding partners. | Res Pract Thromb Haemost | 2022 | 35873217 | PubTator, text mining | PubMed |
| Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector. | Nat Commun | 2022 | 35871249 | PubTator, text mining | PubMed |
| Urinary Podocyte Excretion Predicts Urinary Protein Selectivity and Renal Prognosis. | Int J Nephrol | 2022 | 35866051 | PubTator, text mining | PubMed |
| Data driven and biophysical insights into the regulation of trafficking vesicles by extracellular matrix stiffness. | iScience | 2022 | 35865140 | PubTator, text mining | PubMed |
Erratum: Author correction to 'Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling' [Acta Pharmaceutica Sinica B 12 (2022) 1198-1212]. | Acta Pharm Sin B | 2022 | 35865100 | PubTator, text mining | PubMed |
| TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR. | Int J Biol Sci | 2022 | 35864968 | PubTator, text mining | PubMed |
| DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | Cancer Med | 2022 | 35864588 | PubTator, text mining | PubMed |
| LncRNA, an Emerging Approach for Neurological Diseases Treatment by Regulating Microglia Polarization. | Front Neurosci | 2022 | 35860297 | PubTator, text mining | PubMed |
| A review of NTRK fusions in cancer. | Ann Med Surg (Lond) | 2022 | 35860155 | PubTator, text mining | PubMed |
| Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review). | Int J Mol Med | 2022 | 35856413 | PubTator, text mining | PubMed |
| Molecular determinants of peri-apical targeting of inositol 1,4,5-trisphosphate receptor type 3 in cholangiocytes. | Hepatol Commun | 2022 | 35852334 | PubTator, text mining | PubMed |
| Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer. | Breast Cancer Res | 2022 | 35850772 | PubTator, text mining | PubMed |
| Editorial: Digital Innovation and Data-Driven Research in Neurodegenerative Diseases. | Front Neurol | 2022 | 35847199 | PubTator, text mining | PubMed |
| Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB. | EMBO J | 2022 | 35844135 | PubTator, text mining | PubMed |
| Human adaptation to high altitude: a review of convergence between genomic and proteomic signatures. | Hum Genomics | 2022 | 35841113 | PubTator, text mining | PubMed |
| Comprehensive Analysis Reveals USP45 as a Novel Putative Oncogene in Pan-Cancer. | Front Mol Biosci | 2022 | 35836933 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4627/papers?page=47